“…The negative impact of SD on hippocampal function is at least partly caused by increased phosphodiesterase (PDE) activity and related suppression of cAMP signaling (Havekes et al, ; Havekes, Park, Tolentino, et al, ; Vecsey et al, ). Because cGMP and cAMP signaling potentially target the same downstream signaling molecules known to be affected by SD (i.e., CREB (Wong, Tann, Ibanez, & Sajikumar, ), LIMK1‐cofilin (Havekes, Park, Tudor, et al, ; Wong et al, ; Zulauf et al, )), cGMP signaling may also be a relevant therapeutic target in this respect. While disrupting effects of SD have been reported for a variety of hippocampal tasks (Havekes & Abel, ; Havekes, Meerlo, & Abel, ), its impact on pattern separation remains to be defined.…”